# Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems

> **NCT07296263** · NA · ENROLLING_BY_INVITATION · sponsor: **Hyperfine** · enrollment: 85 (estimated)

## Conditions studied

- Intra-axial Tumors
- Extra-axial Tumors
- Infection/Inflammatory Lesions

## Interventions

- **DEVICE:** Portable MRI (pMRI)
- **DRUG:** Gadolinium-Based Contrast Agent (GBCA)

## Key facts

- **NCT ID:** NCT07296263
- **Lead sponsor:** Hyperfine
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-30
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07296263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07296263, "Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT07296263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*